Inpatient and Pharmacy Management

Episode 727: Dealing with and preventing negative interactions with other professionals

Pharmacy Joe

JULY 3, 2022

How I deal with negative interactions has been heavily influenced by “Pharmacy Chris.” Before graduating pharmacy school, I worked as an intern in a community pharmacy, and Chris was the pharmacy manager. One thing I noticed about Chris was that his mood was unflappable.

Physician Offices

Physician Offices Community Pharmacies Pharmacy Management Inpatient

Episode 727: Dealing with and preventing negative interactions with other professionals

Pharmacy Joe

JULY 3, 2022

How I deal with negative interactions has been heavily influenced by “Pharmacy Chris.” Before graduating pharmacy school, I worked as an intern in a community pharmacy, and Chris was the pharmacy manager. One thing I noticed about Chris was that his mood was unflappable.

Physician Offices

Physician Offices Community Pharmacies Pharmacy Management Inpatient

Four Times When My Pharmacy Had To Say “No” — And We Weren’t Just Being Difficult

The Happy PharmD

JANUARY 4, 2023

As a pharmacy manager, I got that a lot. I always felt my pharmacy department was treated like second-class citizens. The pharmacy always had to give in. . My pharmacy was a hospital pharmacy. We filled prescriptions for inpatients. “Oh, you’re just being difficult!” I don’t know.

Episode 727: Dealing with and preventing negative interactions with other professionals

Episode 727: Dealing with and preventing negative interactions with other professionals

Trending Sources

Four Times When My Pharmacy Had To Say “No” — And We Weren’t Just Being Difficult

Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor

OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWD

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Taletrectinib Gains FDA Approval for Locally Advanced or Metastatic ROS1+ NSCLC

FDA Approves Tablet Formulation of Zanubrutinib for All Indications

What Pharmacists Should Know About Medicare Open Enrollment 2023

Impact of a Community-Based Specialty Pharmacist in Identifying Drug Therapy Problems for New Adult Oncology Patients

Real-World Data on Expanding Step-Up Dosing Administration of Bispecific T-Cell Engagers in the Outpatient Setting

Study: Prevalence and Clinical Implications of MASLD in Type 2 Diabetes

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies

What Pharmacists Should Know About Medicare Open Enrollment 2024

10 Opportunities to Leverage for Career Advancement

Clinical Manifestations of Acute, Chronic Graft-vs-Host Disease With PTCy in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

High Response Rates With Talquetamab Plus Teclistamab in Triple-Class Refractory Multiple Myeloma

Review Demonstrates Impaired Quality of Life in Children With Pneumococcal Disease Despite Variations in Study Methodologies

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Sequencing of Liposomal Daunorubicin/Cytarabine Versus Hypomethylating Agents Plus Venetoclax for Secondary Acute Myeloid Leukemia

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Investigating the Pharmacist’s Role in Psychedelic-Assisted Psychotherapy for Patients With Cancer

Do We Really Pay More for Prescription Drugs in the United States?

Stay Connected